Test Kit is in vitro diagnostic (IVD) test for qualitative detection of the nucleocapsid protein antigen in nasopharyngeal swabs from individuals.
Benefit of Antigen Test
Epithod®616 COVID-19 Ag can detect Antigen produced after virus infection in the human nasopharynx.
This test kit is a gold nanoparticle-based immunoassay for semi-quantitative determination with Epithod®616 analyzer.
As the number of people with infection rapidly increases on the pandemic, the importance of rapid antigen diagnostic kits has been highlighted and required all over the world.
Rapid antibody diagnostic kit is particularly useful in emergency situations where viral infections spread rapidly to the community, making it possible to quick and exact tests.
Epithod®616 COVID-19 Ag can be performed by non-experts and the cost is very economical. Fast test time based on flow-through method has strong advantages with high accuracy to prevent virus transmission and assure timely treatment of patient healthcare.
SPECIFICATIONS
Assay Principle | Immuno-chromatography |
Sample type | Sterile swab / UTM |
Test result | Negative and Positive with cut-off-index |
Assay time | 3 minutes |
Storage condition | R1,R2, R3 and Cartridge : 2 ~ 10 °C |
ORDER INFORMATION
Contents | Cat.No | Specification | Packaging | |
Analyzer | Epithod®616 | E0M100 | 1 unit | Standard carton |
Test Kits | Epithod®616 COVID-19 Ag | E0CA00 | 45 tests/kit | (*) Special cold packing |
Auxiliaries | Sterile swab | AUX001 | 45 pcs/pack | Standard carton |
Pipette tips | AUX301 | Yellow tip, 1,000 pcs/pack | Standard carton | |
Thermal printer paper | AUX401 | 5 rolls/pack | Standard carton | |
Barcode reader | AUX402 | RQST | Standard carton | |
External battery | AUX403 | RQST | Standard carton |
(*) Special packing charge will be imposed under MOQ.